DalsnaFinance › IPOs › Kyverna Therapeutics › IPO
Kyverna Therapeutics, Inc. completed its initial public offering on NASDAQ on February 8, 2024, pricing at $22.00 a share.
| Ticker | KYTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 8, 2024 |
| Offering price | $22.00 |
| Shares offered | 14,500,000 |
| Total raised | $319M |
Kyverna Therapeutics, Inc. sold 14,500,000 shares at $22.00 each on NASDAQ. Multiplied out, that is $319 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $319 million total recorded for the deal.
Kyverna Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Kyverna Therapeutics, Inc.. This page is general information, not investment advice.